Scimago Lab
powered by Scopus
eISSN: 1941-5923
call: +1.631.629.4328
Mon-Fri 10 am - 2 pm EST


Medical Science Monitor Basic Research


Agranulocytosis Induced by Sinomenine Hydrochloride

Unknown ethiology, Challenging differential diagnosis, Diagnostic / therapeutic accidents, Management of emergency care, Adverse events of drug therapy

Juerong Chen, Bing Zhong, Yong Wang

China (mainland) Department of Rheumatology, Southwest Hospital, Third Military Medical University, Chongqing, China (mainland)

Am J Case Rep 2017; 18:959-962

DOI: 10.12659/AJCR.904519

Available online: 2017-09-06

Published: 2017-09-06


BACKGROUND: Sinomenine hydrochloride is an alkaloid that is extracted from the Chinese herbal plant Sinomenium acutum, and is used as a herbal medicine in the treatment or rheumatic disease. This report is the first to describe a case of sinomenine hydrochloride-induced agranulocytosis.
CASE REPORT: A 44-year-old woman with systemic lupus erythematosus (SLE) and systemic sclerosis (SSc) was treated with sinomenine hydrochloride and developed agranulocytosis with a neutrophil count of 0.01×10^9/L. She subsequently developed an opportunistic bacterial infection. Bone marrow aspiration showed a severe reduction in the proportion of mature granulocytes. The patient discontinued sinomenine hydrochloride therapy and was treated with granulocyte colony-stimulating factor (G-CSF) and antibiotics. The patient showed a return to normal granulocyte levels within ten days of discontinuing treatment with sinomenine hydrochloride.
CONCLUSIONS: The findings of this case report show that monitoring of bone marrow function and granulocyte levels should be performed during treatment with sinomenine hydrochloride.

Keywords: agranulocytosis, Opportunistic Infections, Sinomenium